Signal active
Investment Firm
Overview
U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the past thirty-plus years of the firm's existence.
Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.
Highlights
1981
Enterprise Software
11-50
576
175
158
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
U.S. Venture Partners, established in 1981 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Video, Digital Media, Video Streaming, Financial Services, Venture Capital, Finance, Internet, Messaging, Angel Investment, Advertising. The organization boasts a portfolio of 577 investments, with an average round size of $29.3M and 158 successful exits. Their recent investments include PodTech, Venrock, National Banana, Yoomba, Global Catalyst Partners. The highest investment round they participated in was $1154.9B. Among their most notable exits are PodTech and Venrock. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
576
57
175
158
Investments
576
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Feb 06, 2024 | IONIX | Enterprise Software | 15.0M |
Feb 20, 2024 | Cagent Vascular | Health Care | 30.0M |
Mar 18, 2024 | Carlsmed | Health Care | 52.5M |
Apr 24, 2024 | Sparrow Pharmaceuticals | Biotechnology | 10.2M |
Exits
158
Funding Timeline
576
0
6
Funding Rounds
576
U.S. Venture Partners has raised 576 rounds. Their latest funding was raised on Apr 24, 2024 from a Venture Round - Sparrow Pharmaceuticals round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Feb 06, 2024 | Series A - IONIX | - | 15.0M | - |
Feb 20, 2024 | Series C - Cagent Vascular | - | 30.0M | - |
Mar 18, 2024 | Series C - Carlsmed | - | 52.5M | - |
Apr 24, 2024 | Venture Round - Sparrow Pharmaceuticals | - | 10.2M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.